Ki-67
Ki-67タンパク質はCBX3との間に相互作用が見られる。
The Ki-67 protein was originally defined by the prototype monoclonal antibody Ki-67, which was generated by immunizing mice with nuclei of the Hodgkin lymphoma cell line L428. The name is derived from the city of origin (Kiel, Germany) and the number of the original clone in the 96-well plate.
↑ “Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer”. European Journal of Cancer (Oxford, England : 1990) 51 (12): 1481–9. (2015). doi:10.1016/j.ejca.2015.03.018. PMID 26074397.
↑ “Ki67 in breast cancer: prognostic and predictive potential”. The Lancet. Oncology 11 (2): 174–83. (2010). doi:10.1016/S1470-2045(09)70262-1. PMID 20152769.
↑ Bánkfalvi A (November 2000). “Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use.